|
ZBED4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.662500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.335600E-01 |
| Normal-vs-Stage2 |
2.976000E-01 |
| Normal-vs-Stage3 |
9.124600E-01 |
| Normal-vs-Stage4 |
4.956400E-01 |
| Stage1-vs-Stage2 |
5.389800E-01 |
| Stage1-vs-Stage3 |
4.805000E-01 |
| Stage1-vs-Stage4 |
2.824600E-01 |
| Stage2-vs-Stage3 |
3.792400E-01 |
| Stage2-vs-Stage4 |
2.609800E-01 |
| Stage3-vs-Stage4 |
5.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.565800E-02 |
| Normal-vs-AfricanAmerican |
6.483400E-01 |
| Normal-vs-Asian |
5.922000E-02 |
| Caucasian-vs-AfricanAmerican |
2.641200E-01 |
| Caucasian-vs-Asian |
2.738200E-03 |
| AfricanAmerican-vs-Asian |
9.517100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.505200E-01 |
| Normal-vs-Female |
4.757800E-02 |
| Male-vs-Female |
2.480800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.384000E-01 |
| Normal-vs-Extreme_Weight |
7.194200E-01 |
| Normal-vs-Obese |
2.590200E-02 |
| Normal-vs-Extreme_Obese |
8.188200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.036400E-01 |
| Normal_Weight-vs-Obese |
2.263800E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.613600E-01 |
| Extreme_Weight-vs-Obese |
4.281800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.897400E-01 |
| Obese-vs-Extreme_Obese |
3.243800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.680000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.614340E-02 |
| Normal-vs-Age(61-80Yrs) |
3.946200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.208100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.608400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.783450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.563780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.242200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.109990E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.986500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.820100E-03 |
| Normal-VS-Type2 PRCC |
3.400300E-02 |
| Normal-VS-KIRP CIMP |
2.441600E-01 |
| Normal-VS-Unclassified PRCC |
9.168200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.68419994511981E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.945000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.065400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.769700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.182980E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.013800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.274000E-01 |
| Normal-vs-N1 |
3.638400E-01 |
| Normal-vs-N2 |
3.970000E-01 |
| N0-vs-N1 |
1.555550E-01 |
| N0-vs-N2 |
6.835200E-01 |
| N1-vs-N2 |
3.654000E-01 |
|
|
